✦ LIBER ✦

Pharmacopsychological properties of DAU 6215 CL, a 5 HT3-antagonist, in phase 1 anhedonia and anxiety performance models

✍ Scribed by Leonard, J.P.; Schilling, J.C.; Lay, T.; Meyer, T.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The Effect of DAU 6215, A Novel 5HT-3 An

✍ F. Borsini; A. Brambilla; R. Cesana; A. Donetti 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 391 KB

Efficacy and tolerability of a new 5HT3-

✍ Del Favero, A.; Ciccarese, G.; Giglietti, A.; Palladino, M.A.; Malacarne, P.; In 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 161 KB

P.3.074 In vivo pharmacological profile

✍ R. Arban; A. Poffe; L. Bettelini; F. Bacchi; P.A. Gerrard; S. Melotto 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 133 KB

F15063, a compound with D2/D3 antagonist

✍ R Depoortère; A L Auclair; L Bardin; L Bruins Slot; M S Kleven; F Colpaert; B Va 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 189 KB

F15063, a compound with D2/D3 antagonist

✍ R Depoortère; L Bardin; A L Auclair; M S Kleven; E Prinssen; F Colpaert; B Vache 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 191 KB

P.3.d.009 F15063, a novel antipsychotic

✍ R. Depoortere; L. Bardin; A.L. Auclair; L. Bruins Slot; M.S. Kleven; A. Newman-T 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 62 KB